Annual Meeting

The specialized metabolism and trafficking of cellular subcompartments

Learn about the Discover BMB 2024 symposium on mitochondria, peroxisomes and chloroplast metabolism
Greg Moorhead Pere Puigserver
By Greg Moorhead and Pere Puigserver
Sept. 19, 2023

Your first biology course probably defined eukaryotes in part as having a group of specialized organelles. These membrane-bound subcompartments of the eukaryotic cell are unique in many ways, especially their specialized biochemistry and metabolism.

The three sessions we have organized for Discover BMB will cover several topics focused on the novel biology and biochemistry of the mitochondria, peroxisome and chloroplast. These sessions will address current research on specific metabolic pathways, with important new insights into the protein structure and trafficking that support the integrity and function of these organelles.

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.

These multidisciplinary talks will provide information not only on the specific biochemical functions of these organelles, but also on their integrative architecture and physiology. In the three sessions, new information will be integrated into general principles of organelle biogenesis and metabolic function.

Keywords: Mitochondria, chloroplast, peroxisome, metabolism, covalent modifications, organelle biogenesis, protein structure and trafficking.

Who should attend: Anyone interested in metabolism, organellar proteomes and the specialized biology of organelles.

Theme song:  “The Cell” by Gojira, because it is such a high-energy song — mitochondria, chloroplasts ...

This session is powered by ATP

Mitochondria, peroxisomes and chloroplast metabolism

Protein covalent modifications and chloroplast metabolism

Chair: Greg Moorhead

Greg MoorheadUniversity of Calgary

Glen UhrigUniversity of Alberta

R. Paul JarvisUniversity of Oxford

Paula MuloUniversity of Turku

Peroxisome biogenesis/metabolism

Chair: Tom Rapoport

Francesca Di CaraDalhousie University

Brooke GardnerUniversity of California, Santa Barbara

Tom RapoportHarvard Medical School; Howard Hughes Medical Institute

Irfan LodhiWashington University in St. Louis

Mitochondria energetics/metabolism

Chair: Erin Goley

Pere PuigserverDana–Farber Cancer Institute; Harvard Medical School

Lena PernasMax Planck Institute for Biology of Ageing

Alexey AmuntsStockholm University

Rebecca VoorheesCalifornia Institute of Technology

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Greg Moorhead
Greg Moorhead

Greg Moorhead is a professor at the University of Calgary, Canada.

Pere Puigserver
Pere Puigserver

Pere Puigserver is a professor at Harvard Medical School/Dana–Farber Cancer Institute.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Cholesterol regulatory genes predict liver transplant outcomes
Journal News

Cholesterol regulatory genes predict liver transplant outcomes

April 10, 2026

Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Journal News

Lipid signatures for a rare neurological disorder

April 10, 2026

Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Journal News

The dual role of asprosin in chronic fatty liver disease

April 8, 2026

Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Journal News

Novel inhibitor targets RAS-driven cancers

April 7, 2026

Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Journal News

Catching tau in the act

April 2, 2026

Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.